Pembrolizumab in Hepatocellular Carcinoma
Clinical trial NCT03419481 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03419481
- Sponsor
- CCTU
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-30
- Primary completion
- 2026-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.